Research Article | Open Access
Maduka Donatus Ughasoro, Anazoeze Jude Madu, Iheoma Clara Kela-Eke, "Evaluation of the Performance of Haemoglobin Colour Scale and Comparison with HemoCue Haemoglobin Assay in Diagnosing Childhood Anaemia: A Field Validation Study", International Journal of Pediatrics, vol. 2019, Article ID 3863070, 5 pages, 2019. https://doi.org/10.1155/2019/3863070
Evaluation of the Performance of Haemoglobin Colour Scale and Comparison with HemoCue Haemoglobin Assay in Diagnosing Childhood Anaemia: A Field Validation Study
Background. Anaemia in children has high mortality. We present the results of assessment of the accuracy of Haemoglobin Colour Scale in identifying anaemia compared with HemoCue assay. Methods. The presence of anaemia in 524 children from four communities was screened using the Haemoglobin Colour Scale (HCS) and HemoCue assay. Independent healthcare providers that estimated the haemoglobin level using Hb-301 haemoglobinometer were different from those that read the colour scale. The sensitivity, specificity, positive predictive value, and negative predictive value were estimated. Results. Of the 524 children surveyed, 44.5% (233/524), 50% (262/524), and 32.2% (168/524) were found to be anaemic using the HemoCue, HCS (p= 0.25), and clinical pallor (p=0.03) respectively. Using the HemoCue as standard, the sensitivity of the HCS and clinical pallor was 89.1% and 72.1%, respectively, and specificity 90.2% and 84.6%, respectively. 74.7 % of the colour scale result was within the 1.0g/dl of the HemoCue reading and 23 % was within 2.0g/dl. Conclusion. The HCS can improve the ability to detect anaemia especially where the use of the HemoCue is not feasible as in the resource poor countries. However, every case of anaemia requires further investigation to determine the underlying causes.
A high proportion of the global population are anaemic  and children are the worse affected [1, 2]. Over the past decades, in addition to clinical detection of anaemia , several innovatory simple and reliable point-of-care diagnostic tests and methods for estimating haemoglobin have been introduced to aid detection of anaemia [2–7] in both developed and developing countries. In developing countries, with the high prevalence of anaemia, the screening for childhood anaemia is often limited to clinical inspection of different sites: conjunctiva, nail bed, palm of the hand, and buccal mucosal with varied outcome .
It is over a decade since WHO introduced the Haemoglobin Colour Scale (HCS) which requires only a drop of blood on a special paper compared with a chart of different shades of red colour and very suitable for resource poor countries [9, 10]. But a systematic review by Critchley and Bates revealed varied sensitivity and specificity of the HCS in detecting anaemia. Most of the studies reported good outcome and recommended the use of the HCS [9, 11], while few reported that the HCS is too inaccurate for general use, particularly places where the HemoCue haemoglobinometer is available . Unfortunately, deployment of the HemoCue haemoglobinometer in sub-Saharan areas (SSA) has being enshrouded with challenges: scarcity and the high cost of HemoCue cuvettes and reliance on a power source (either battery or electricity).
It is over a decade since the HCS was introduced and it is rarely used in paediatric practice especially on children under 5 years old, in Nigeria and most SSA. Currently, there is a paucity of studies on the validity of the HCS on children population [13, 14] and our literature search revealed that none of such studies has been conducted in Nigeria.
In this study, we evaluated the diagnostic accuracy of the HCS, among children, implemented by different healthcare workers located in the urban and rural health facilities compared with the validated digital HemoCue analyzer using a standard protocol. The outcome provided evidence required for policy reform in the use of HCS on children in Nigeria.
2.1. Ethical Consideration
The University of Nigeria Teaching Hospital Enugu, Health Research and Ethics Committee, gave approval for the study. The parents/caregivers of the children gave written consent before their children were allowed to participate in the study. Anaemic children were given haematinic and referred to paediatric clinic for further evaluation.
2.2. Study Design
The study was a double blinded field validation of the HCS conducted in four communities randomly selected from Enugu and Abia states, both in southeast Nigeria.
2.3. Sample Size
A minimum sample size of three hundred and seventy-four children was estimated based on sensitivity and specificity of clinical pallor of 70%, respectively , 95% confidential interval, and anaemia prevalence of 42%.
2.4. Patient Recruitment
Stratified multistage cluster sampling was used to select the wards where the study took place. One local government area (LGA) was randomly selected from the list of LGAs in each of the study states. In the selected LGA, one rural ward and one urban ward were selected using the simple random sampling. A cluster comprises streets in the urban area and hermits in the rural areas. The households with children under 10 years of age were identified and enumerated. The households to participate were randomly selected from the list of the enumerated households. Consent to participate was obtained from the head of the household or their representative. A household was defined as a family unit “eating from the same pot”. Those who gave their consent to participate in the study were invited to the designated study health centre in their locality.
2.5. Data and Sample Collection
A standard protocol was followed for blood collection. The pulp of the finger or the heel of the foot was cleaned with alcohol solution. The skin was punctured with a lancet and allow free flow of blood, not squeezed on the cuvette of the HemoCue 301 machine for the haemoglobin estimation and one filter paper for the HCS.
Haemoglobin Colour Scale: Two staff members of the designated health centres were trained for 2 days on the use of the HCS (CoPark, Hamburg, Germany) which has six standard shades of red colour corresponding to haemoglobin levels of 4g/dl, 6g/dl, 8g/dl, 10g/dl, 12g/dl, and 14g/dl. To determine the haemoglobin level using the HCS, a single drop of blood was placed on an absorbent paper test strip, matched against the colour scale standards, and viewed through a circular window on the colour shade until a matching colour which corresponds to Hb value is determined. There is provision for intermediate odd values, e.g., 5g/dl, 7g/dl, 9g/dl, 11g/dl, and 13g/dl, if the healthcare worker judged the colour of the drop of blood on the test strip to fall between two standards. This assessment was done in well illuminated place during day light to reduce the effect of poor lightening or coloured light on the readings.
Another independent researcher, blinded to the haemoglobin level estimated using HCS, estimated the haemoglobin level using a validated HemoCue 301 machine. All the procedures of blood collection adhered to the World Health Organization (WHO) standard of universal precaution .
2.6. Data Analysis
The data was entered in SPSS version 20. The children were grouped as not anaemic based on WHO cutoff of ≥ 11g/dl, and anaemic if Hb level was less than 11g/dl ; in this study, sensitivity and specificity of the HCS were based on comparing the haemoglobin results with those of the HemoCue readings. The results were matched to determine the extent of closeness or discrepancies of the HCS to HemoCue reading. Sensitivity is true positive/true positive plus false negative, and specificity is true negative/true negative plus false positive. True positives were those children whose HCS reading was the same as the HemoCue reading or varied with ± 1g/dl, HemoCue Hb reading. True negatives were those whose HCS estimate differed from the HemoCue Hb reading by ≥ 2g/dl, being either higher or lower. False positives were those whose HCS estimate was 1.1g/dl but < 2g/dl more than the HemoCue Hb estimate. False negatives were those whose HCS estimate is 1g/dl but < 2g/dl less than the HemoCue Hb estimate. The significant value was p ≤0.05.
Out of 573 children who were involved in the study, 524 children had complete data and were included in the analysis. Of the 524 children under 10 years included in the analysis, 307 children were from urban areas (167 from Abakpa, Enugu; 140 from ward 1 Umuahia central, Umuahia) and 216 children were from rural areas (106 from Ibagwa, Enugu; 110 from Nkwoegwu, Umuahia). The numbers of male and female children were 297 (56.7%) and 226 (43.3%), respectively. The mean age was 46.65 (± 34.2) months.
Using HemoCue, 233 (233/524, 44.5%) children were found to be anaemic compared to 262 (262/524, 50%) children found to be anaemic using HCS, and the difference was not statistically significant (p = 0.25). The sensitivity, specificity, positive predictive value, and negative predictive value of the HCS for detection of anaemia compared to HemoCue 301 as the standard were represented in Table 1. HCS had sensitivity of 89.1% and specificity of 90.2%. The positive predictive value (PPV) and negative predictive value (NPV) of HCS were 89.1% and 90,2% respectively.
Using HCS, 233 (233/524, 44.5%) children were found to be anaemic compared to 168 (168/524, 32.2%) children found to be anaemic based on clinical assessment, and the difference was statistically significant (p = 0.03), Table 1. The sensitivity, specificity, positive predictive value, and negative predictive value of clinical detection of anaemia compared to HemoCue as the standard were 72.1%, 84.6%, 72.1%, and 84.6%, respectively.
The proportion of HCS results that differed from the HemoCue assay with ± 1g/dl, 1.1 g/dl but ≤ 2g/dl, and > 2g/dl were 74.7%, 23%, and 2.3%, respectively. See Table 2.
The prevalence of childhood anaemia was high and is similar to what has been reported [18, 19]. This has exceeded the 40% cutoff for severe category according to the WHO classification of anaemia in a population based on the prevalence estimated from blood levels of haemoglobin [2, 20]. By this current high prevalence, compared to the previous WHO estimates , Nigeria has not made much impact on its fight to control anaemia, at least in the region where the study was conducted. Thus, there is a need to reevaluate the existing anaemia control strategies in Nigeria, especially in the area of early detection of childhood anaemia.
Our findings confirm that the Haemoglobin Colour Scale showed good agreement with that obtained with the HemoCue assay. This is similar to what have been reported in other previous studies [7, 9]. The Haemoglobin Colour Scale has been found to be accurate in diagnosing severe and moderately severe anaemia in high-prevalence area in hands of community health workers in real-life field condition, after a brief training . Furthermore, the sensitivity and specificity of the HCS in identifying anaemic children were impressive for a screening tool. Although efforts should be made to use WHO Hb values of 11g/dl as cutoff for anaemia rather than the 10g/dl classification according to the HCS instruction , interestingly, studies have shown that there is increase in the performance of the HCS as the haemoglobin level descends towards the range of severe anaemia cutoffs [11, 13, 15]. Since the specificity of the HCS at this low haemoglobin cutoff remains relatively high, coupled with the excessive morbidity and mortality risk associated with severe anaemia, the use of HCS can be recommended for the detection and treatment of severe childhood anaemia in primary care settings in resource poor countries that lack the sophisticated modern equipment for detecting anaemia.
The performance of clinical assessment of anaemia in children is less than optimal. This has been a common finding in many published studies [21–25] reporting clinical assessment of pallor. Despite this poor performance of clinical assessment of anaemia, it still remains the sole possible method of prompt evaluation for anaemia in primary healthcare facilities in developing countries. Our experience and that of Luby et al.  demonstrated that the act of clinical assessment of anaemia can be learned by parents/caregivers and other nonphysicians with minimal training. Their performance can be improved by providing varying colour charts that represent three broad categories: not anaemic, anaemic, and very anaemic. This will reduce the subjectivity associated with comparing parents’ palms which oftentimes are anaemic themselves.
One limitation in this study was the small number of children that had severe (5) and moderate (29) anaemia compared to mild (80) anaemia , which limited the ability to test the accuracy of the detection of anaemia of HCS at different grades of anaemia using relativity observers curve. Furthermore, haemoglobin level of individuals varies over a very wide range which makes estimation of average, and thus application of the Bland-Altman analysis which is based on average or difference between a standard (HemoCue) and a reference value (HCS), not feasible. A future designed study that will ensure relatively equal number of children with different grades of anaemia will be required to determine the efficiency of HCS at varying levels of anaemia.
In conclusion, the HCS is reliable option for haemoglobin assay if access to HemoCue assay is limited. However, every case of childhood anaemia should be properly investigated doing a minimum of blood film examination, to detect the underlying cause(s) and treat, not just correct, the anaemia.
|HCS:||Haemoglobin Colour Scale|
|LGA:||Local government area|
|NPV:||Negative predictive value|
|PPV:||Positive predictive value|
|WHO:||World Health Organization.|
The data used to support the findings of this study are included within the article.
In this study we observed that Haemoglobin Colour Scale (HCS) performance was close to that of HemoCue in detecting childhood anaemia, while clinical detection of childhood anaemia was suboptimal.
The Ethics and Health Research Committee of the University of Nigeria Teaching Hospital, Ituku/Ozalla, Enugu, reviewed the protocol and gave approval before the study was commenced.
Verbal and written consent was obtained from the parents of the children before they were enrolled in the study. In the consent, the purpose and procedures of the study were explained to them. Those who gave approval were asked to sign the consent form. Those children who were found to be anaemic were given iron supplementation and referred to a paediatrician for further evaluation.
Conflicts of Interest
We declare no conflicts of interest.
UMD conceived the study; Maduka Donatus Ughasoro, Anazoeze Jude Madu, and Iheoma Clara Kela-Eke designed the study and participated in data collection. Maduka Donatus Ughasoro analyzed data and wrote the initial manuscript draft. Maduka Donatus Ughasoro, Anazoeze Jude Madu, and Iheoma Clara Kela-Eke reviewed the report and approved the final manuscript.
The study was part of a bigger project sponsored by Tertiary Educational Trust (TET) Fund of Nigeria accessed through the University of Nigeria Nsukka. We thank the Head of Health Department of the two local government areas, Umuahia North and Enugu East, where the study was conducted. We appreciate all the parents that allowed their children to participate in this study. We appreciate the efforts of officers-in-charge of the four health centres that participated in this study for assisting us in community mobilization as well as making the sites ready for the study. We also want to thank Barrister Frank Ejiofor, the professional script editor who reviewed this manuscript before submission.
- World Health Organization, “Worldwide prevalence of anaemia 1993-2005 : WHO global database on anaemia,” edited by Bruno de Benoist, Erin McLean, Ines Egli and Mary Cogswell, 2008, https://apps.who.int/iris/handle/10665/43894.
- WHO, Haemoglobin Concentration for the Diagnosis of Anaemia and Assessment of Severity, Vitamin and Mineral Nutrition Information System, World Health Organization, Geneva, 2011.
- S. P. Luby, P. N. Kazembe, S. C. Redd et al., “Using clinical signs to diagnose anaemia in African children,” Bulletin of the World Health Organuzation, vol. 5, pp. 477–482, 1995.
- F. Sanchis-Gomar, J. Cortell-Ballester, H. Pareja-Galeano, G. Banfi, and G. Lippi, “Hemoglobin point-of-care testing,” Journal of Laboratory Automation, vol. 18, no. 3, pp. 198–205, 2013.
- L. D. Morris, A. Osei-Bimpong, D. McKeown, D. Roper, and S. M. Lewis, “Evaluation of the utility of the HemoCue 301 haemoglobinometer for blood donor screening,” Vox Sanguinis, vol. 93, no. 1, pp. 64–69, 2007.
- C. Crowley, G. Montenegro-Bethancourt, N. W. Solomons, and K. Schumann, “Validity and correspondence of non-invasively determined hemoglobin concentrations by two trans-cutaneous digital measuring devices,” Asia Pacific Journal of Clinical Nutrition, vol. 21, no. 2, pp. 191–200, 2012.
- S. M. Lewis, G. J. Stott, and K. J. Wynn, “An inexpensive and reliable new haemoglobin colour scale for assessing anaemia,” Journal of Clinical Pathology, vol. 51, no. 1, pp. 21–24, 1998.
- M. D. Ughasoro, A. J. Madu, and I. C. Kela -Eke, “Clinical anaemia detection in children of varied skin complexion: a community-based study in southeast, nigeria,” Journal of Tropical Pediatrics, vol. 63, no. 1, pp. 23–29, 2017.
- C. F. Ingram and S. M. Lewis, “Clinical use of WHO haemoglobin colour scale: validation and critique,” Journal of Clinical Pathology, vol. 53, no. 12, pp. 933–937, 2000.
- G. J. Stott and S. M. Lewis, “A simple and reliable method for estimating haemoglobin,” Bulletin of the World Health Organization, vol. 73, no. 3, pp. 369–373, 1995.
- J. Critchley and I. Bates, “Haemoglobin colour scale for anaemia diagnosis where there is no laboratory: a systematic review,” International Journal of Epidemiology, vol. 34, no. 6, pp. 1425–1434, 2005.
- J. J. Paddle, “Evaluation of the Haemoglobin colour scale and comparison with the HemoCue haemoglobin assay,” Bulletin of the World Health Organization, vol. 80, no. 10, pp. 813–816, 2002.
- A. Montresor, M. Albonico, N. Khalfan et al., “Field trial of a haemoglobin colour scale: an effective tool to detect anaemia in preschool children,” Tropical Medicine & International Health, vol. 1, no. 2, pp. 129–133, 2000.
- K. A. Lindblade, K. Mwololo, A. M. Van Eijk et al., “Evaluation of the WHO Haemoglobin Colour Scale for diagnosis of anaemia in children and pregnant women as used by primary health care nurses and community health workers in western Kenya,” Tropical Medicine & International Health, vol. 11, no. 11, pp. 1679–1687, 2006.
- A. Kalantri, M. Karambelkar, R. Joshi, S. Kalantri, U. Jajoo, and G. Malaga, “Accuracy and reliability of pallor for detecting anaemia: a hospital-based diagnostic accuracy study,” PLoS One, vol. 5, no. 1, p. e8545, 2010.
- E. H. Siegel, R. J. Stoltzfus, S. K. Khatry, S. C. LeClerq, J. Katz, and J. M. Tielsch, “Epidemiology of anemia among 4- to 17-month-old children living in south central Nepal,” European Journal of Clinical Nutrition, vol. 60, no. 2, pp. 228–235, 2006.
- World Health Organization, UNICEF & United Nations University. Iron Deficiency: Indicators for Assessment and Strategies for Prevention, WHO, Geneva, Switzerland, 1998.
- M. D. Ughasoro, I. J. Emodi, H. U. Okafor, and B. C. Ibe, “Prevalence and risk factors of anaemia in paediatric patients in South-East Nigeria,” South African Journal of Child Health, vol. 9, no. 1, pp. 14–17, 2015.
- Worldwide prevalence of anaemia 1993-2005. WHO Global Database on Anaemia. http://www.who.int/iris.
- P. P. Shah, S. A. Desai, D. K. Modi, and S. P. Shah, “Assessing diagnostic accuracy of hemoglobin colour scale in real-life setting,” Journal of Health, Population and Nutrition, vol. 32, no. 1, pp. 51–57, 2014.
- IroN Deficiency Anaemia: Assessment, Prevention, and Control, A guide for programme managers, World Health Organization, Geneva, 2001.
- R. J. Stoltzfus, A. Edward-Raj, M. L. Dreyfuss et al., “Clinical pallor is useful to detect severe anemia in populations where anemia is prevalent and severe,” Journal of Nutrition, vol. 129, no. 9, pp. 1675–1681, 1999.
- G. Santra, “Usefulness of examination of palmar creases for assessing severity of anemia in Indian perspective: a study from a tertiary care center,” International Journal of Medicine and Public Health, vol. 5, no. 2, pp. 169–172, 2015.
- T. N. Sheth, N. K. Choudhry, M. Bowes, and A. S. Detsky, “The relation of conjunctival pallor to the presence of anemia,” Journal of General Internal Medicine, vol. 12, no. 2, pp. 102–106, 1997.
- O. L. Hung, N. S. Kwon, A. E. Cole et al., “Evaluation of the physician's ability to recognize the presence or absence of anemia, fever, and jaundice,” Academic Emergency Medicine, vol. 7, no. 2, pp. 146–156, 2000.
Copyright © 2019 Maduka Donatus Ughasoro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.